MedPath

Standardization of the MRI scanning method in the diagnosis of N-factor in primary lung cancer

Not Applicable
Conditions
primary lung cancer
Registration Number
JPRN-UMIN000016312
Lead Sponsor
Kyusyu University
Brief Summary

stage per patient There was no significant difference in sensitivity and accuracy between three modalities by two readers. However, specificity of FDG-PET/CT in reader 2 were superior to those of DWI and STIR in reader 1. N-stage per LN station Sensitivity of DWI in reader 2 was superior to that of FDG-PET/CT in reader 2. Specificity and accuracy of FDG-PET/CT in reader 2 was superior to those of STIR and DWI in both readers.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
158
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who was already enrolled in this study 2)Patient of contraindication to an MRI (e.g. after implantation of a pacemaker) 3)Patient who couldn't carry out FDG-PET/CT before the oparation 4)Patient with a history of an operation of primary lung cancer 5)Patient with a history of radiation irradiation to a thorax 6)During medication by diabetes or blood glucose level >=150mg/dL 7)Pregnant, parturient, or breastfeeding women 8)Patients who was diagnosis of small cell lung cancer, a benign tumor, and other nonneoplastic diseases in pathology organizational diagnosis 9)Any others judged ineligible as a subject by the investigator/sub-investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath